GlassScriptPhysician profile
Justin L Cole
NPI 1588053052
$14,392.19
in general payments reported to CMS, 2019-2025
65 companies · $2,772 in 2025
The $2,772 reported for 2025 was more than what 96% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,437 · 2022: $2,931 · 2023: $2,938 · 2024: $3,315 · 2025: $2,772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,931 · Education: $93.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,930.57 |
| Education | $93.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $985.74 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $866.56 | 2021-2025 | Austedo Xr, Austedo, Austedo Xr |
| Acadia Pharmaceuticals INC | $779.68 | 2021-2025 | Nuplazid, Daybue |
| Sk Life Science, INC. | $776.35 | 2021-2025 | |
| Ucb, INC. | $751.99 | 2021-2025 | Briviact, Nayzilam, Rystiggo |
| Novartis Pharmaceuticals Corporation | $719.28 | 2021-2025 | |
| Pfizer INC. | $718.58 | 2022-2025 | |
| Biogen, INC. | $639.17 | 2021-2025 | Vumerity, Leqembi, Skyclarys |
| Argenx US, INC. | $507.30 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Lilly USA, LLC | $480.49 | 2021-2025 | Kisunla, Emgality, Reyvow |
| Jazz Pharmaceuticals INC. | $464.13 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $424.85 | 2023-2025 | Nuedexta, Rexulti |
| Amgen INC. | $424.60 | 2021-2025 | Uplizna, Aimovig |
| Lundbeck LLC | $343.41 | 2021-2025 | Vyepti, Rexulti |
| Ani Pharmaceuticals, INC. | $342.90 | 2024-2025 | Purified Cortrophin Gel |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $339.43 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $333.96 | 2021-2025 | Ultomiris, Soliris |
| Genzyme Corporation | $329.62 | 2021-2023 | |
| Genentech USA, INC. | $327.27 | 2021-2025 | Ocrevus Zunovo, Ocrevus |
| Neurocrine Biosciences, INC. | $287.96 | 2021-2025 | Ingrezza, Ongentys |
| Catalyst Pharmaceuticals, INC. | $249.42 | 2023-2025 | Fycompa |
| Celgene Corporation | $222.04 | 2021-2023 | Zeposia |
| Medtronic, INC. | $215.22 | 2021-2022 | |
| Axsome Therapeutics, INC. | $196.53 | 2023-2025 | Symbravo, Sunosi |
| Biohaven Pharmaceutical Holding Company LTD. | $191.68 | 2022 | |
| Neurelis, INC. | $153.11 | 2023-2024 | Valtoco |
| Sunovion Pharmaceuticals INC. | $152.16 | 2021-2022 | |
| Eisai INC. | $141.82 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $140.56 | 2021-2025 | Wainua, Andexxa |
| E.R. Squibb & Sons, L.L.C. | $126.38 | 2021-2025 | Eliquis |
| Impel Pharmaceuticals INC. | $125.83 | 2023 | Trudhesa |
| Mdd US Operations, LLC | $118.18 | 2021-2024 | Apokyn, Xadago, Apokyn |
| Biohaven Pharmaceuticals, INC. | $99.33 | 2021 | |
| Kyowa Kirin, INC. | $96.40 | 2021-2023 | Nourianz |
| Takeda Pharmaceuticals U.S.A., INC. | $90.59 | 2023-2025 | Hyqvia |
| Emd Serono, INC. | $90.58 | 2021-2024 | |
| Allergan, INC. | $88.94 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $86.59 | 2024-2025 | Amvuttra, Givlaari |
| Amylyx Pharmaceuticals, INC. | $82.82 | 2023 | Relyvrio |
| Corium, LLC | $70.43 | 2022-2023 | Adlarity |
| Sumitomo Pharma America, INC. | $68.35 | 2023-2024 | Aptiom |
| Mallinckrodt Hospital Products INC. | $64.78 | 2021-2025 | Acthar |
| Tanabe Pharma America, INC. | $63.04 | 2021-2023 | |
| Acorda Therapeutics, INC | $62.89 | 2022-2023 | Inbrija |
| Horizon Therapeutics Plc | $57.67 | 2022-2023 | Uplizna |
| Livanova USA, INC. | $54.99 | 2022-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Merz Pharmaceuticals, LLC | $54.18 | 2024-2025 | Xeomin |
| Supernus Pharmaceuticals, INC. | $48.87 | 2021 | |
| Janssen Pharmaceuticals, INC | $35.58 | 2021 | |
| Csl Behring | $30.57 | 2022 | |
| Novocure INC. | $24.51 | 2023 | Optune |
| C2n Diagnostics, LLC | $23.14 | 2025 | Precivityad2 |
| Grifols USA, LLC | $21.62 | 2021 | |
| Xeris Pharmaceuticals, INC. | $20.40 | 2024 | Keveyis |
| Adc Therapeutics America, INC. | $19.04 | 2025 | |
| Sanofi-Aventis U.S. LLC | $18.55 | 2021 | |
| Vanda Pharmaceuticals INC. | $18.06 | 2024 | Ponvory |
| Phathom Pharmaceuticals, INC. | $17.81 | 2024 | Voquezna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.05 | 2025 | Caplyta |
| Mylan Specialty L.P. | $15.67 | 2022 | |
| Cala Health, INC. | $15.61 | 2025 | Cala Kiq |
| Amneal Pharmaceuticals LLC | $15.07 | 2024 | Ongentys |
| Boston Scientific Corporation | $15.01 | 2025 | Wavewriter Alpha Prime 16 |
| Idorsia Pharmaceuticals US INC | $14.54 | 2023 | Quviviq |
| Kedrion Biopharma, INC. | $14.31 | 2024 | Albuked, Rhogam Ultra-Filtered Plus, Kedrab |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.